Long-Term Safety, Rollover Study of Adjunctive Everolimus in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures Who Continue to Benefit from Everolimus Treatment after Completion of EXIST-3


Yapici Z. , Fan P. -. , Lawson J. A. , Belousova E., Gazri H. E. , Ridolfi A., ...Daha Fazla

13th European Congress on Epileptology, Vienna, Avusturya, 26 - 30 Ağustos 2018, cilt.59 identifier

  • Cilt numarası: 59
  • Basıldığı Şehir: Vienna
  • Basıldığı Ülke: Avusturya